Request Deal Involvement

Elanco completed the acquisition of Animal Health Business of Bayer for $7.6bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Finsbury Glover Hering

pr advisors

Finsbury Glover Hering

Bank of America

financial advisors

Bank of America

Credit Suisse

financial advisors

Credit Suisse

Linklaters

legal advisors

Linklaters

PricewaterhouseCoopers

legal advisors

PricewaterhouseCoopers

Sullivan & Cromwell

legal advisors

Sullivan & Cromwell

Goldman Sachs

financial advisors

Goldman Sachs

Paul Weiss Rifkind Wharton & Garrison

legal advisors

Paul Weiss Rifkind Wharton & Garrison

Duff & Phelps

financial advisors

Duff & Phelps

Hengeler Mueller

legal advisors

Hengeler Mueller

Davis Polk & Wardwell

legal advisors to financial advisors

Davis Polk & Wardwell

Khaitan & Co

legal advisors

Khaitan & Co

or

Principals

BAYER AG

vendor

BAYER AG

BAYER (ANIMAL HEALTH UNIT)

target

BAYER (ANIMAL HEALTH UNIT)

ELANCO ANIMAL HEALTH

bidder

ELANCO ANIMAL HEALTH

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Elanco completed the acquisition of Animal Health Business of Bayer for $7.6bn.